Literature DB >> 23864628

Phenotypic and functional characterization of circulating polyomavirus BK VP1-specific CD8+ T cells in healthy adults.

Michiel C van Aalderen1, Ester B M Remmerswaal, Kirstin M Heutinck, Anja ten Brinke, Hanspeter Pircher, René A W van Lier, Ineke J M ten Berge.   

Abstract

The human polyomavirus BK virus (BKV) establishes a latent and asymptomatic infection in the majority of the population. In immunocompromised individuals, the virus frequently (re)activates and may cause severe disease such as interstitial nephritis and hemorrhagic cystitis. Currently, the therapeutic options are limited to reconstitution of the antiviral immune response. T cells are particularly important for controlling this virus, and T cell therapies may provide a highly specific and effective mode of treatment. However, little is known about the phenotype and function of BKV-specific T cells in healthy individuals. Using tetrameric BKV peptide-HLA-A02 complexes, we determined the presence, phenotype, and functional characteristics of circulating BKV VP1-specific CD8(+) T cells in 5 healthy individuals. We show that these cells are present in low frequencies in the circulation and that they have a resting CD45RA(-) CD27(+) memory and predominantly CCR7(-) CD127(+) KLRG1(+) CD49d(hi) CXCR3(hi) T-bet(int) Eomesodermin(lo) phenotype. Furthermore, their direct cytotoxic capacity seems to be limited, since they do not readily express granzyme B and express only little granzyme K. We compared these cells to circulating CD8(+) T cells specific for cytomegalovirus (CMV), Epstein-Barr virus (EBV), and influenza virus (Flu) in the same donors and show that BKV-specific T cells have a phenotype that is distinct from that of CMV- and EBV-specific T cells. Lastly, we show that BKV-specific T cells are polyfunctional since they are able to rapidly express interleukin-2 (IL-2), gamma interferon (IFN-γ), tumor necrosis factor α, and also, to a much lower extent, MIP-1β and CD107a.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23864628      PMCID: PMC3754019          DOI: 10.1128/JVI.01540-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  Human CD8(+) T-cell differentiation in response to viruses.

Authors:  René A W van Lier; Ineke J M ten Berge; Laila E Gamadia
Journal:  Nat Rev Immunol       Date:  2003-12       Impact factor: 53.106

2.  BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses.

Authors:  Emily Blyth; Leighton Clancy; Renee Simms; Shivashni Gaundar; Philip O'Connell; Kenneth Micklethwaite; David J Gottlieb
Journal:  Transplantation       Date:  2011-11-27       Impact factor: 4.939

3.  Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.

Authors:  Gert Van Assche; Marc Van Ranst; Raf Sciot; Bénédicte Dubois; Séverine Vermeire; Maja Noman; Jannick Verbeeck; Karel Geboes; Wim Robberecht; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

4.  Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation.

Authors:  Naofumi Takemoto; Andrew M Intlekofer; John T Northrup; E John Wherry; Steven L Reiner
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

5.  Dynamics of urinary polyomavirus shedding in healthy adult women.

Authors:  Courtney L Kling; Alexandra T Wright; Sophie E Katz; Gloria B McClure; J Suzette Gardner; Jason T Williams; Natalie M Meinerz; Robert L Garcea; John A Vanchiere
Journal:  J Med Virol       Date:  2012-09       Impact factor: 2.327

6.  Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Authors:  Susanne J Szabo; Brandon M Sullivan; Claudia Stemmann; Abhay R Satoskar; Barry P Sleckman; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

7.  BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.

Authors:  Yiping Chen; Jennifer Trofe; Jennifer Gordon; Patrick Autissier; E Steve Woodle; Igor J Koralnik
Journal:  J Clin Virol       Date:  2008-03-04       Impact factor: 3.168

8.  Antibodies to BK virus structural and tumor antigens in human sera from normal persons and from patients with various diseases, including neoplasia.

Authors:  A Corallini; G Barbanti-Brodano; M Portolani; P G Balboni; M P Grossi; L Possati; C Honorati; M La Placa; A Mazzoni; A Caputo; U Veronesi; S Orefice; G Cardinali
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

9.  Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1).

Authors:  David Voehringer; Marie Koschella; Hanspeter Pircher
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

10.  Phenotypic and functional separation of memory and effector human CD8+ T cells.

Authors:  D Hamann; P A Baars; M H Rep; B Hooibrink; S R Kerkhof-Garde; M R Klein; R A van Lier
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

View more
  14 in total

1.  A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients.

Authors:  Benjamin J D Weist; Patrizia Wehler; Linda El Ahmad; Michael Schmueck-Henneresse; Jason M Millward; Mikalai Nienen; Avidan U Neumann; Petra Reinke; Nina Babel
Journal:  Kidney Int       Date:  2015-07-29       Impact factor: 10.612

2.  Clonal evolution of CD8+ T cell responses against latent viruses: relationship among phenotype, localization, and function.

Authors:  Ester B M Remmerswaal; Paul L Klarenbeek; Nuno L Alves; Marieke E Doorenspleet; Barbera D C van Schaik; Rebecca E E Esveldt; Mirza M Idu; Ester M M van Leeuwen; Nelly van der Bom-Baylon; Antoine H C van Kampen; Sven D Koch; Hanspeter Pircher; Frederike J Bemelman; Anja Ten Brinke; Frank Baas; Ineke J M Ten Berge; Rene A W van Lier; Niek de Vries
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

Review 3.  BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.

Authors:  George R Ambalathingal; Ross S Francis; Mark J Smyth; Corey Smith; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

4.  Infection history determines the differentiation state of human CD8+ T cells.

Authors:  Michiel C van Aalderen; Ester B M Remmerswaal; Niels J M Verstegen; Pleun Hombrink; Anja ten Brinke; Hanspeter Pircher; Neeltje A Kootstra; Ineke J M ten Berge; René A W van Lier
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

Review 5.  Tissue-resident memory T cells in the urogenital tract.

Authors:  Loreto Parga-Vidal; Michiel C van Aalderen; Regina Stark; Klaas P J M van Gisbergen
Journal:  Nat Rev Nephrol       Date:  2022-01-25       Impact factor: 28.314

Review 6.  Tissue-resident memory T cells in the kidney.

Authors:  Nariaki Asada; Pauline Ginsberg; Nicola Gagliani; Hans-Willi Mittrücker; Ulf Panzer
Journal:  Semin Immunopathol       Date:  2022-04-11       Impact factor: 9.623

Review 7.  The polyomavirus puzzle: is host immune response beneficial in controlling BK virus after adult hematopoietic cell transplantion?

Authors:  G Satyanarayana; F M Marty; C S Tan
Journal:  Transpl Infect Dis       Date:  2014-05-19       Impact factor: 2.228

Review 8.  Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus.

Authors:  Xin Wang; Shyam A Patel; Michael Haddadin; Jan Cerny
Journal:  Ther Adv Infect Dis       Date:  2021-05-24

9.  Specificity and dynamics of effector and memory CD8 T cell responses in human tick-borne encephalitis virus infection.

Authors:  Kim Blom; Monika Braun; Jolita Pakalniene; Laura Dailidyte; Vivien Béziat; Margit H Lampen; Jonas Klingström; Nina Lagerqvist; Torbjörn Kjerstadius; Jakob Michaëlsson; Lars Lindquist; Hans-Gustaf Ljunggren; Johan K Sandberg; Aukse Mickiene; Sara Gredmark-Russ
Journal:  PLoS Pathog       Date:  2015-01-22       Impact factor: 6.823

10.  Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients.

Authors:  Amy K Wesa; Maja Mandic; Jennifer L Taylor; Stergios Moschos; John M Kirkwood; William W Kwok; James Harold Finke; Walter J Storkus
Journal:  Front Oncol       Date:  2014-09-29       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.